This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Insmed Incorporated. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Adrien Cerdan: Innovator in DPP1 Inhibitors
Introduction
Adrien Cerdan is a notable inventor based in Strasbourg, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of reversible DPP1 inhibitors. His work is crucial for advancing treatments for diseases that can be managed through the administration of these inhibitors.
Latest Patents
Adrien Cerdan holds a patent for "Reversible DPP1 inhibitors and uses thereof." This patent includes compounds of Formula (I), along with their pharmaceutically acceptable salts or deuterated forms. The patent outlines pharmaceutical compositions that incorporate these compounds and methods for their use in treating diseases that are responsive to DPP1 inhibitors. He has 1 patent to his name.
Career Highlights
Cerdan is currently associated with Insmed Incorporated, a company that focuses on innovative therapies for serious diseases. His role at Insmed allows him to contribute to the development of groundbreaking treatments that can improve patient outcomes.
Collaborations
One of his notable collaborators is Paola Ciapetti, with whom he has worked on various projects related to his patent and its applications in the pharmaceutical industry.
Conclusion
Adrien Cerdan's work in the field of DPP1 inhibitors exemplifies the impact of innovative thinking in medicine. His contributions are paving the way for new treatment options that can significantly benefit patients.